Evidence map›Paper›PMID 42649623›Full record

ReviewIUBMB life2026

Black Sheep: Pseudokinases Bucking the Trend to Reveal Non-Catalytic Kinase Functions.

James M Murphy, Natalia Jura, Peter D Mace

Abstract readReview
In one paragraph

Review in IUBMB life, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

James M MurphyWalter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.ORCID https://orcid.org/0000-0003-0195-3949
Natalia JuraCardiovascular Research Institute, University of California San Francisco, San Francisco, California, USA.ORCID https://orcid.org/0000-0001-5129-641X
Peter D MaceDepartment of Biochemistry, Faculty of Biomedical Sciences, University of Otago, Dunedin, New Zealand.ORCID https://orcid.org/0000-0003-2175-9537

Funding

The Cancer Cell Map Initiative v2.0U54CA274502 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Trey Ideker · 2022 to 2026
$14.2M
Structural and Functional Studies of HER ReceptorsR35GM139636 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Natalia Jura · 2021 to 2026
$2.5M
Health Research Council of New Zealand 26-0641Marsden Fund UOO2505National Health and Medical Research Council 2034104NCI NIH HHS U54 CA274502NIGMS NIH HHS R35 GM139636NIH HHS NCI U54CA274502NIH HHS NIGMS R35GM139636
6 · The paper itself

Abstract

Pseudokinases are the catalytically-dead counterparts of protein kinases and, over the past 20 years, have increasingly garnered attention as crucial signaling entities-comprehensively dispelling the possibility that they are merely evolutionary remnants or cellular passengers. The field has been framed by a sequence-based definition of a pseudokinase, where the absence of one or more of the three critical catalytic residues required for phosphoryl transfer in conventional protein kinases has allowed their classification. As a result, pseudokinases have been defined by their dissimilarity to active kinases, meaning they are the outcasts or black sheep of the kinome. Pseudokinases are prevalent in nature, accounting for 10% or more of the kinase complement throughout phyla, and have been reported to mediate diverse functions in controlling the activities of other enzymes allosterically, mediating signaling complex assembly, serving as conformational switches and as negative regulators of signaling flux. Here, we review our current understanding of the varied pseudokinase functions as a window toward understanding non-catalytic functions of conventional protein kinases, the challenges associated with defining pseudokinases-especially in cases where cryptic catalytic activities have been reported-and the emergence of pseudokinases as pharmacological targets.

Indexed as

Protein KinasesAnimalsCatalysisHumansPhosphorylationSignal TransductionProtein Kinasescatalytically‐deadprotein interactionspseudoenzymesignal transduction

Identifiers

PMID42649623
PMCPMC13519141

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.